MELD vs Child-Pugh and creatinine-modified Child-Pugh score for predicting survival in patients with decompensated cirrhosis
Related Experiment Videos
George V Papatheodoridis1, Evangelos Cholongitas, Eleni Dimitriadou
12nd Department of Internal Medicine, National University of Medical School, Hippokration General Hospital, 114 Vas. Sophias Ave., 115 27 Athens, Greece. gpapath@cc.uoa.gr
Aim:
Model of End-stage Liver Disease (MELD) score has recently gained wide acceptance over the old Child-Pugh score in predicting survival in patients with decompensated cirrhosis, although it is more sophisticated. We compared the predictive values of MELD, Child-Pugh and creatinine-modified Child-Pugh scores in decompensated cirrhosis.
Methods:
A cohort of 102 patients with decompensated cirrhosis followed-up for a median of 6 mo was studied. Two types of modified Child-Pugh scores estimated by adding 0-4 points to the original score using creatinine levels as a sixth categorical variable were evaluated.
Results:
The areas under the receiver operating characteristic curves did not differ significantly among the four scores, but none had excellent diagnostic accuracy (areas: 0.71-0.79). Child-Pugh score appeared to be the worst, while the accuracy of MELD was almost identical with that of modified Child-Pugh in predicting short-term and slightly better in predicting medium-term survival. In Cox regression analysis, all four scores were significantly associated with survival, while MELD and creatinine-modified Child-Pugh scores had better predictive values (c-statistics: 0.73 and 0.69-0.70) than Child-Pugh score (c-statistics: 0.65). Adjustment for gamma-glutamate transpeptidase levels increased the predictive values of all systems (c-statistics: 0.77-0.81). Analysis of the expected and observed survival curves in patients subgroups according to their prognosis showed that all models fit the data reasonably well with MELD probably discriminating better the subgroups with worse prognosis.
Conclusion:
MELD compared to the old Child-Pugh and particularly to creatinine-modified Child-Pugh scores does not appear to offer a clear advantage in predicting survival in patients with decompensated cirrhosis in daily clinical practice.
Insights
The Model of End-stage Liver Disease (MELD) score and creatinine-modified Child-Pugh scores show similar predictive value for decompensated cirrhosis survival. Neither MELD nor modified Child-Pugh offers a clear advantage over the other in clinical practice.
Area of Science:
- Hepatology
- Clinical Prognostics
- Medical Statistics
Background:
- Decompensated cirrhosis requires accurate survival prediction.
- The Model of End-stage Liver Disease (MELD) score is increasingly used, replacing the Child-Pugh score.
- The utility of creatinine-modified Child-Pugh scores remains under investigation.
Purpose of the Study:
- To compare the predictive accuracy of MELD, Child-Pugh, and creatinine-modified Child-Pugh scores.
- To evaluate these scores in predicting survival in patients with decompensated cirrhosis.
Main Methods:
- A cohort of 102 patients with decompensated cirrhosis was studied.
- Creatinine levels were incorporated into the Child-Pugh score to create modified versions.
- Receiver operating characteristic curves and Cox regression analysis were used for comparison.
Main Results:
- No significant difference in diagnostic accuracy was found among the four scoring systems (AUC: 0.71-0.79).
- MELD and creatinine-modified Child-Pugh scores demonstrated comparable or slightly better predictive values than the original Child-Pugh score.
- Adjusting for gamma-glutamate transpeptidase improved the predictive value of all systems.
Conclusions:
- The MELD score does not offer a clear advantage over creatinine-modified Child-Pugh scores for predicting survival in decompensated cirrhosis.
- Current scoring systems show moderate predictive accuracy, suggesting room for improvement in clinical practice.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug